EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Inhibition of microRNA-660-5p decreases breast cancer progression through direct targeting of TMEM41B

Valeria Villarreal-García, José Roberto Estupiñan-Jiménez, Vianey Gonzalez-Villasana, Pablo E Vivas-Mejía, Marienid Flores-Colón, Irma Estefanía Ancira-Moreno, Patricio Adrián Zapata-Morín, Claudia Altamirano-Torres, José Manuel Vázquez-Guillen, Cristina Rodríguez-Padilla, Recep Bayraktar, Mohamed H Rashed und 3 weitere

Hereditas · 2024

DOI: 10.1186/s41065-024-00357-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hereditas, 2024. Verfasst von Valeria Villarreal-García und 14 weiteren Autor:innen. Beteiligte Einrichtung: Facultad de Ciencias Biológicas, Departamento de Biología Celular y Genética, Universidad Autónoma de Nuevo León, San Nicolás de los Garza, Nuevo Leó…. Hauptthemen laut MEDLINE: MicroRNAs, Breast Neoplasms, Cell Proliferation, Gene Expression Regulation, Neoplastic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, National Institute of General Medical Sciences (NIGMS) Support for Research Excellence (SuRE) Program (R16), Fondo Sectorial de Investigación para la Educación CB2017-2018, Programa Presupuestario F003 of the Consejo Nacional de Humanidades, Ciencia y Tecnología (CONA….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Breast cancer is the most prevalent cancer among women worldwide. Most breast cancer-related deaths result from metastasis and drug resistance. Novel therapies are imperative for targeting metastatic and drug-resistant breast cancer cells. Accumulating evidence suggests that dysregulated microRNAs (miRNAs) promote breast cancer progression, metastasis, and drug resistance. Compared with healthy breast tissue, miR-660-5p is notably overexpressed in breast cancer tumor tissues. However, the downstream effectors of miR-660-5p in breast cancer cells have not been fully elucidated. Our aim was to investigate the role of miR-660-5p in breast cancer cell proliferation, migration, invasion, and angiogenesis and to identify its potential targets.

Results

Our findings revealed significant upregulation of miR-660-5p in MDA-MB-231 and MCF-7 cells compared with MCF-10 A cells. Furthermore, inhibiting miR-660-5p led to notable decreases in the proliferation, migration, and invasion of breast cancer cells, as well as angiogenesis, in HUVEC cells. Through bioinformatics analysis, we identified 15 potential targets of miR-660-5p. We validated TMEM41B as a direct target of miR-660-5p via Western blot and dual-luciferase reporter assays.

Conclusions

Our study highlights the upregulation and involvement of miR-660-5p in breast cancer cell proliferation, migration, invasion, and angiogenesis. Additionally, we identified TMEM41B as a direct target of miR-660-5p in breast cancer cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsBreast NeoplasmsCell ProliferationGene Expression Regulation, NeoplasticCell MovementHumansFemaleCell Line, TumorMembrane ProteinsDisease ProgressionMCF-7 CellsHuman Umbilical Vein Endothelial CellsNeovascularization, Pathologic

Stichwörter der Autor:innen

Breast CancerCancer ProgressionMicroRNAsTransmembrane Protein 41BmiR-660-5p

Substanzen

MicroRNAsMIRN660 microRNA, humanMembrane Proteins

Autor:innen und Institutionen

  • Facultad de Ciencias Biológicas, Departamento de Biología Celular y Genética, Universidad Autónoma de Nuevo León, San Nicolás de los Garza, Nuevo León, México.
  • Facultad de Ciencias Biológicas, Departamento de Biología Celular y Genética, Universidad Autónoma de Nuevo León, San Nicolás de los Garza, Nuevo León, México. vianey.gonzalezvl@uanl.edu.mx.
  • Department of Biochemistry, Medical Sciences Campus, University of Puerto Rico, San Juan, Puerto Rico. pablo.vivas@upr.edu.
  • Comprehensive Cancer Center, Medical Sciences Campus, University of Puerto Rico, San Juan, Puerto Rico. pablo.vivas@upr.edu.
  • Department of Biochemistry, Medical Sciences Campus, University of Puerto Rico, San Juan, Puerto Rico.
  • Comprehensive Cancer Center, Medical Sciences Campus, University of Puerto Rico, San Juan, Puerto Rico.

Förderung

  • NIGMS NIH HHS
  • National Institute of General Medical Sciences (NIGMS) Support for Research Excellence (SuRE) Program (R16)
  • Fondo Sectorial de Investigación para la Educación CB2017-2018, Programa Presupuestario F003 of the Consejo Nacional de Humanidades, Ciencia y Tecnología (CONA…
  • Consejo Nacional de Humanidades, Ciencia y Tecnología (CONAHCYT) scolarship

Zitieren

APA

Villarreal-García, V., Estupiñan-Jiménez, J. R., Gonzalez-Villasana, V., Vivas-Mejía, P. E., Flores-Colón, M., Ancira-Moreno, I. E., Zapata-Morín, P. A., Altamirano-Torres, C., Vázquez-Guillen, J. M., Rodríguez-Padilla, C., Bayraktar, R., Rashed, M. H., Ivan, C., Lopez-Berestein, G., & Reséndez-Pérez, D. (2024). Inhibition of microRNA-660-5p decreases breast cancer progression through direct targeting of TMEM41B. Hereditas. https://doi.org/10.1186/s41065-024-00357-5

Vancouver

Villarreal-García V, Estupiñan-Jiménez JR, Gonzalez-Villasana V, Vivas-Mejía PE, Flores-Colón M, Ancira-Moreno IE, et al. Inhibition of microRNA-660-5p decreases breast cancer progression through direct targeting of TMEM41B. Hereditas. 2024. doi:10.1186/s41065-024-00357-5

BibTeX
@article{VillarrealGarca2024,
  author = {Villarreal-García, Valeria and Estupiñan-Jiménez, José Roberto and Gonzalez-Villasana, Vianey and Vivas-Mejía, Pablo E and Flores-Colón, Marienid and Ancira-Moreno, Irma Estefanía and Zapata-Morín, Patricio Adrián and Altamirano-Torres, Claudia and Vázquez-Guillen, José Manuel and Rodríguez-Padilla, Cristina and Bayraktar, Recep and Rashed, Mohamed H and Ivan, Cristina and Lopez-Berestein, Gabriel and Reséndez-Pérez, Diana},
  title = {Inhibition of microRNA-660-5p decreases breast cancer progression through direct targeting of TMEM41B},
  journal = {Hereditas},
  year = {2024},
  doi = {10.1186/s41065-024-00357-5}
}
Kostenlos starten →